$LAHO - For now, it looks like we dodged 2 bullet's. I
$LAHO - For now, it looks like we dodged 2 bullet's. I cannot begin to tell everyone how close that was. For now, it looks like we have a reprieve.
In the PR they state:
Bullet #1:
"Lans Holdings Inc. is pleased to announce that it has successfully secured a 180-day extension to complete the acquisition of 100% of Global Stem Cells Group Inc."
Translation: After they messed up with the SEC, I mean it's the screw up of the century. They went to GSCG, hat in hand, and begged for an extension. Because with the SEC suspension, they wouldn't be able to complete the terms of the merger in the time frame allotted per the contract.
Who knows what kind of behind the scenes concessions LAHO had to make there. I'll let everyone's imagination run wild with that one. GSCG could have very easily told LAHO, "nope deals off." And just like that, it would have been over. OVER!
Bullet #2:
"The Company has agreed to enter into a settlement with the SEC."
Translation: LAHO was able to cut a deal with the SEC on this. Again, who knows what kind of behind the scenes concessions LAHO had to make there. I'll let everyone's imagination run wild with that one too.
The encouraging part to me is that LAHO literally performed 2 miracles in 72 working day hours from the SEC suspension on 9/6/2019.
Here's the next hurdle and this is the biggest reason why they needed the 180 day extension. We are going to the grey sheets. This is a Finra thing not an SEC thing. I do believe LAHO needs to get back to the pink sheets to be able to complete the merger.
"The Company intends to now file a form 10 to reregister its common shares with the SEC and to locate a market maker to sponsor the Company in a 211 filing to reinstate trading of the Company’s shares."
Translation: There is no "intend" to it. LAHO absolutely has to file a form 10 to reregister its common shares with the SEC. Then the company absolutely has to get a MM to sponsor them in a 211 filing to reinstate the trading, (in the pink sheets) of the Company’s shares. This is the SEC requirement to get back to the pink sheets.
The company has a long road ahead of them and only 180 days to get it all done. They have to get back to the pink sheets before the merger can be completed, which means that we could be back just as soon as they get compliant with the SEC and get a MM on board in the 211 filing. How long is that? LAHO just pulled off 2 miracles in 72 working hours from the SEC suspension. And I'm sure there is a lot of people in the trading community that didn't think they could / would get this far. So we will see.
I have no idea how it will trade when it opens back up on 9/20/19. My guess is that we will have a lot of sellers at first but I really don't know.
But I do know that if they pull this off, (so far so good), it will be a big deal both for them, and for the trading community.
There is risk in all investments.......All IMO of course.
3
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...
Continue Reading
Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...
Continue Reading
Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....
Continue Reading
Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...
Continue Reading
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
Top 5 Most Recently Viewed Articles
Canadian Stocks See Notable Gains The Canadian stock market has shown encouraging signs of growth lately, with various sectors playing a part in this upward movement. The S&P/TSX Composite Index achieved a remarkable increase of 0.57%, marking a significant point in its trading history. Key Sectors Driving Market Growth The rise in stock prices can largely be credited to...
Continue Reading
Stepping into Michigan It might not be a Wall Street headliner, but Bookmark Medical's move into Michigan sure says a lot about their growth ambitions. On August 3, 2026, the Nashville-based healthcare group wrapped up acquiring Village Medical Michigan. This is Bookmark's maiden voyage into the Great Lake State, where it's taken over the reins of seven primary care...
Continue Reading
Astrotech Corporation Reports Strong Fiscal Performance Recently, Astrotech Corporation (NASDAQ: ASTC) announced its financial results for the fiscal year that ended on June 30. The report highlights notable advancements from its subsidiary, 1st Detect, and how these developments are contributing to overall revenue and growth potential. Key Financial Highlights The...
Continue Reading
Neptune Flood Research Report Offers Insights on NFIP Transition Recent research indicates that private flood insurers may be capable of taking on 95% of policies from the NFIP, helping to mitigate federal financial exposure. Neptune Flood Research Group has published a comprehensive report analyzing the U.S. flood insurance market. The study emphasizes the challenges...
Continue Reading
Valerio Therapeutics Announces Strategic Refocus Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) has made a pivotal announcement regarding its strategic business direction. The company has decided to halt all clinical trials, including the ongoing VIO-01 trial. This decision comes in response to significant financing challenges impacting the organization. While...
Continue Reading